Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000386105 | SCV000395076 | uncertain significance | Saldino-Mainzer syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000386105 | SCV001417925 | benign | Saldino-Mainzer syndrome | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV000386105 | SCV004810155 | uncertain significance | Saldino-Mainzer syndrome | 2024-04-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004021042 | SCV004886193 | uncertain significance | Inborn genetic diseases | 2023-12-12 | criteria provided, single submitter | clinical testing | The c.3955_3960delGCCAAG (p.A1319_K1320del) alteration is located in exon 29 (coding exon 27) of the IFT140 gene. This alteration consists of an in-frame deletion of 6 nucleotides between nucleotide positions c.3955 and c.3960, resulting in the deletion of 2 residues. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Center for Genomic Medicine, |
RCV000256471 | SCV000322798 | likely pathogenic | Orofacial-digital syndrome III; Asphyxiating thoracic dystrophy 1 | no assertion criteria provided | research | ||
Clinical Genetics, |
RCV001795477 | SCV002034619 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001795477 | SCV002035672 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001795477 | SCV002038205 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004752816 | SCV005344621 | uncertain significance | IFT140-related disorder | 2024-04-04 | no assertion criteria provided | clinical testing | The IFT140 c.3955_3960del6 variant is predicted to result in an in-frame deletion (p.Ala1319_Lys1320del). This variant was reported in the homozygous state in an individual with short-rib thoracic dysplasia/oral-facial-digital syndrome (Patient 12DG1103, Table S3, Shaheen et al. 2016. PubMed ID: 27894351; Table S1, Shamseldin et al. 2021. PubMed ID: 34645488). This variant is reported in 0.36% of alleles in individuals of Ashkenazi Jewish descent in gnomAD, including one homozygote. This variant has been reported in ClinVar with conflicting interpretations of likely pathogenic (1), uncertain (4), and benign (1) (https://www.ncbi.nlm.nih.gov/clinvar/variation/266103/). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |